Pancreatic cancer treatment and research at Dana-Farber
Pancreatic cancer is the fourth leading cause of cancer-related death in males and the fifth leading cause of cancer death in females in the U.S. Because the early stages of this disease often do not cause symptoms, it is typically diagnosed at an advanced stage. Therefore, the survival rate is poor compared to other types of cancer.
Related Stories
- Dana-Farber researchers and their Harvard collaborators are probing the genetics of pancreatic cancer
- DFCI scientists create lab model of human pancreatic cancer that could yield advances in early diagnosis, treatment of lethal disease
